📣 Back to School开学季 - VIP通行证5折优惠!蓝莓、Offer多多同步优惠
查看: 527| 回复: 0
跳转到指定楼层
上一主题 下一主题
收起左侧

(ASAP) 全奖博士职位2023 Fall 纽约州立大学宾汉姆顿分校招收Pharmaceutical Sci.

全局:
招生
学校名称: State University of New York at Binghamton
专业: BME
入学年度: 2023
入学学期: Fall
导师个人主页: https://theMeiLab.com

注册一亩三分地论坛,查看更多干货!

您需要 登录 才可以下载或查看附件。没有帐号?注册账号

x
纽约州立大学(宾汉姆顿分校)(SUNY Binghamton)药剂科学系(Pharmaceutical Sciences)MEI Lab招全奖博士生。
感兴趣的同学可直接联系Dr. Kuo-Ching Mei (kmei at binghamton dot edu). (as soon as possible)

The Molecular Engineering Innovation (MEI) Laboratory at SUNY Binghamton is looking for highly motivated and talented students to join our team. We currently have one opening for a PhD position with full financial support. The student is expected to enroll in the Pharmaceutical Sciences PhD program in  Fall 2023 and will work in the field of drug/gene/cell delivery for immunoengineering.

Requirements:
BS in Pharmacy, Pharmaceutical Sciences, Molecular Biology, Biomedical Engineering, Chemical Engineering, or a closely related area.
MS with project experience in NanoMedicine and organic synthesis or MedChem with cell-based screening experiences is preferred.

Experience with one of the following areas is highly desired: organic synthesis, gene delivery, molecular biology
Experience with confocal microscopy, flow cytometry, WB, ELISA, sequencing, IVIS, IHC, animal works, flash chromatography is a plus.

Interested candidates should send a CV, cover letter and transcripts to Dr. Kuo-Ching Mei (kmei at binghamton dot edu).
Full application is expected by end of January 2023 (rolling application until end of March 2023, perspective students should apply ASAP).
TOEFL needed, GRE not required.

上一篇:A PostDoc and multiple PhD student positions in UNSW
下一篇:香港科技大学机械及航空航天工程系副系主任李志刚教授招收2023秋季博士生
您需要登录后才可以回帖 登录 | 注册账号
隐私提醒:
  • ☑ 禁止发布广告,拉群,贴个人联系方式:找人请去🔗同学同事飞友,拉群请去🔗拉群结伴,广告请去🔗跳蚤市场,和 🔗租房广告|找室友
  • ☑ 论坛内容在发帖 30 分钟内可以编辑,过后则不能删帖。为防止被骚扰甚至人肉,不要公开留微信等联系方式,如有需求请以论坛私信方式发送。
  • ☑ 干货版块可免费使用 🔗超级匿名:面经(美国面经、中国面经、数科面经、PM面经),抖包袱(美国、中国)和录取汇报、定位选校版
  • ☑ 查阅全站 🔗各种匿名方法

本版积分规则

>
快速回复 返回顶部 返回列表